Similarly, in the breast cancer cell line MCF-7 and in epithelial primary cultured cells, we observed that KGF treatment interferes with the capacity of tamoxifen to block cell proliferation, whereas KGFR silencing completely restores tamoxifen efficacy. This evidence concerns the gene FGFR2 and breast carcinoma.